UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000033359 |
|---|---|
| Receipt number | R000038015 |
| Scientific Title | Validation study of the hypouricemic effect of a 6-week continuous intake of amino acid mixture on serum uric acid level |
| Date of disclosure of the study information | 2018/07/30 |
| Last modified on | 2019/01/17 15:09:47 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Validation study of the hypouricemic effect of a 6-week continuous intake of amino acid mixture on serum uric acid level
Acronym
Validation study of the hypouricemic effect of a 6-week continuous intake of amino acid mixture on serum uric acid level
Scientific Title
Validation study of the hypouricemic effect of a 6-week continuous intake of amino acid mixture on serum uric acid level
Scientific Title:Acronym
Validation study of the hypouricemic effect of a 6-week continuous intake of amino acid mixture on serum uric acid level
Region
| Japan |
Condition
Condition
Healthy adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study was to verify the effect of continuous intake of amino acid mixtures on serum uric acid levels in healthy adult men and women aged 20 to 65 years whose serum uric acid levels are 6.6 mg/dl or more and 7.9 mg/dl or less, respectively.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Serum uric acid levels
Key secondary outcomes
Urate clearance,Urinary uric acid excretion
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
6-week intake of the test food
Wash out
6-week intake of the placebo
Interventions/Control_2
6-week intake of the placebo
Wash out
6-week intake of the test food
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1.Age: 20 years or older, less than 65 years
2.Gender: Male and female Japanese nationality
3.Patients who have shown a serum uric acid level of 7.9 mg/dl or higher and 6.6 mg/dl or lower in both the primary screening and the secondary screening.
Key exclusion criteria
1.Persons with or who have a history of diseases such as diabetes mellitus, liver disease, kidney disease, or heart disease.
2.Currently, exercise therapy and diet therapy are performed under the supervision of a physician.
3.Persons with diseases requiring continuous medication
4.Persons with a history of serious illness requiring medication.
5.Patients with a history of drug or food allergy
6.Patients who are currently taking health foods and supplements that affect uric acid levels (e.g., those containing chitosan, anserine, chrysanthemum polyphenols, PA-3, etc.)
7.Subjects who are currently taking drugs or quasi-drugs that affect uric acid levels
8.Anthropometric, physical examination, and laboratory test values that significantly deviate from the reference range on the pre-examination basis.
9.Subjects who are pregnant, breast-feeding, or willing to become pregnant during the study period
10.Patients with a current or past history of psychiatric disorders (depression, etc.)
11.Employees working during night shifts, etc.
12.Alcoholism, drug dependence, and drug abusers who are or have a history of treatment
13.Subjects who have participated in other human clinical studies within the past 3 months or are expected to participate in other human clinical studies during the study period.
14.Other than the above, the principal investigator judged the subject to be inappropriate.
Target sample size
32
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Ochitani Daisuke |
Organization
HUMA R&D CORP
Division name
Clinical Development Division
Zip code
Address
Round Cross Tamachi 10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan
TEL
81-3-3431-1260
ochitani@huma-rd.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Ochitani Daisuke |
Organization
HUMA R&D CORP
Division name
Clinical Development Division
Zip code
Address
Round Cross Tamachi 10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan
TEL
81-3-3431-1260
Homepage URL
ochitani@huma-rd.co.jp
Sponsor or person
Institute
HUMA R&D CORP
Institute
Department
Personal name
Funding Source
Organization
Asahi Group Holdings,Ltd
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 07 | Month | 30 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 06 | Month | 08 | Day |
Date of IRB
Anticipated trial start date
| 2018 | Year | 07 | Month | 31 | Day |
Last follow-up date
| 2018 | Year | 11 | Month | 21 | Day |
Date of closure to data entry
| 2018 | Year | 11 | Month | 30 | Day |
Date trial data considered complete
| 2018 | Year | 12 | Month | 18 | Day |
Date analysis concluded
| 2018 | Year | 12 | Month | 28 | Day |
Other
Other related information
Management information
Registered date
| 2018 | Year | 07 | Month | 11 | Day |
Last modified on
| 2019 | Year | 01 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038015
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
